Quick Answer
REVIVA PHARMACEUTICALS HOLDINGS, INC. reported Common Stock Shares Outstanding of 5.87 million shares for the year ending 2025.
- REVIVA PHARMACEUTICALS HOLDINGS, INC. showed an increase of +148.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from REVIVA PHARMACEUTICALS HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2019 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: 2.60 million shares | Q4 2018: 2.60 million shares | Q2 2019: 2.61 million shares | Q3 2019: 2.61 million shares | Q4 2019: 2.62 million shares | Q1 2020: 2.70 million shares | Q2 2020: 2.74 million shares | Q3 2020: 2.81 million shares | Q1 2021: 9.23 million shares | Q2 2021: 13.39 million shares | Q3 2021: 13.39 million shares | Q1 2022: 15.13 million shares | Q2 2022: 14.43 million shares | Q3 2022: 20.44 million shares | Q1 2023: 20.45 million shares | Q2 2023: 22.65 million shares | Q3 2023: 20.65 million shares | Q1 2024: 27.92 million shares | Q2 2024: 29.82 million shares | Q3 2024: 33.44 million shares | Q1 2025: 46.74 million shares | Q2 2025: 68.00 million shares | Q3 2025: 96.34 million shares.
- Over the full 9 years of available data (2019 to 2025), REVIVA PHARMACEUTICALS HOLDINGS, INC.'s Common Stock Shares Outstanding has grown by 125.7%.
- Historical annual values: Fiscal year 2025: 5.87 million shares | Fiscal year 2024: 2.36 million shares | Fiscal year 2023: 27.92 million shares | Fiscal year 2022: 20.45 million shares | Fiscal year 2021: 14.43 million shares | Fiscal year 2020: 9.23 million shares | Fiscal year 2020: 9.23 million shares | Fiscal year 2020: 2.70 million shares | Fiscal year 2019: 2.60 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: